Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 078140

Daebonglsco.,Ltd

Official website

KOSDAQ-listed pharmaceutical and cosmetic ingredient company developing a GLP-1 analog obesity treatment among its API pipeline.

As of 2026-10-08, Daebonglsco.,Ltd has 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1986 and listed on KOSDAQ in 2005, Daebong LS is a company specializing in active pharmaceutical ingredients (APIs) and functional cosmetic ingredients. It produces APIs for respiratory, hypertension, and gastrointestinal treatments as well as natural and fusion-synthesized functional cosmetic ingredients, and is co-developing a GLP-1 analog obesity treatment (code-named L) with an Indian CDMO under an NDA and MOU, alongside a nail fungus treatment (E), hypertension treatment (A), and heart failure and peptic ulcer treatments (V). Consolidated revenue for the period grew 8.6% year-over-year to KRW 102.1 billion, and its subsidiary PNK Skin Research Center provides human application testing for cosmetics, beauty devices, and health functional foods.

Products & technology

  • APIs (respiratory, hypertension, gastrointestinal treatments)Active pharmaceutical ingredients supplied to domestic drug makers
  • Functional cosmetic ingredients (natural and fusion-synthesized)Raw materials for cosmetics

R&D and key agreements

Source: DART corporate disclosure

L(비만치료제) · 비만/당뇨 · 인도 CDMO 공동연구, NDA·MOU 체결 · Ionic-liquid and sonochemistry synthesis method patented; global obesity drug market projected to grow from USD 19.037bn (2023) to USD 37.367bn (2028)

L(진해거담제, 개량신약) · 진해거담 · DMF 등록 준비중

A(고혈압치료제) · 고혈압 · 비임상시험 진행중

E(조갑진균치료제) · 조갑진균증 · DMF등록 및 IND신청 준비 · Technology evaluation grade BB

V(심부전치료제) · 심부전 · 제제연구단계

V(위궤양·십이지장궤양치료제) · 위궤양 및 십이지장궤양 · 일본 제약사와 공동개발

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 123 more patents

AI reads

MAA server logs · IP-verified
23
Times AI engines pulled Daebonglsco.,Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

23
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

5
live 0
Last 7 days
17
live 0
Last 30 days
23
live 0
All time
  • OpenAIOAI-SearchBot17
  • GoogleGoogleOther2
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 7, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Daebonglsco.,Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition